Tuberculous transverse myelitis: Case report and review of the literature

Clinical Pulmonary Medicine

Volumn 12, Issue 1, 2005, Pages 46-52

  Putruele, Ana María ^a   Legarreta, Cora Gabriela ^a   Limongi, Leticia ^a   Rossi, Santiago Enrique ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; METHYLPREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; STEROID; TUBERCULOSTATIC AGENT;

ADULT; BACILLUS; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FEMALE; HUMAN; MILIARY TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPLEGIA; REVIEW; SPINAL CORD; SPINAL CORD COMPRESSION; TUBERCULOSIS;

EID: 12344310062     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000151496.45606.83     Document Type: Review

References (57)

1. Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002;59:499-505.
2. Berman M, Feldman S, Alter M, et al. Acute transverse myelitis: Incidence and etiologic considerations. Neurology. 1981;31:966-971.
3. Jeffery DR, Mandler RN, Davis LE. Transverse myelitis: retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and para infectious events. Arch Neurol. 1993;50:532-535.
4. Kerr DA, Ayetey H. Immunopathogenesis of acute transverse myelitis. Curr Opin Neurol. 2002;15:339-347.
5. Bastian HC. Special diseases of the spinal cord. In: Quain R, ed. A Dictionary of Medicine Including General Pathology, General Therapeutics, Hygiene, and the Diseases Peculiar to Women and Children/by Various Writers. London: Longmans, Green; 1882:1479-1483.
6. Rivera TM. Viruses. JAMA. 1929;92:1147-1152.
7. Al Deeb SM, Yaqub BA, Bruyn GW, et al. Acute transverse myelitis: a localized form of postinfectious encephalomyelitis. Brain. 1997;120:1115-1122.
8. Adams RD, Victor M, Ropper AH. Multiple sclerosis and allied demyelinative disease. In: Adams RD, Victor M, Ropper AH, eds. Principles of Neurology. New York: McGraw-Hill; 1997:902-927.
9. Hughes RA, Mair WG. Acute necrotic myelopathy with pulmonary tuberculosis. Brain. 1977;100:223-238.
10. Bahemuka M, Murungi JH. Tuberculosis of the nervous system: a clinical, radiological and pathological study of 39 consecutive cases in Riyadh, Saudi Arabia. J Neurol Sci. 1989;90:67-76.
11. Silber MH, Willcox PA, Bowen RM, et al. Neuromyelitis optica (Devic's syndrome) and pulmonary tuberculosis. Neurology. 1990;40:934-938.
12. O'Riordan JI, Gallagher HL, Thompson AJ, et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry. 1996;60:382-387.
13. Barbizet J, Degos JD, Meyrignac C. Acute neuromyelitis optica and acute pulmonary tuberculosis. Rev Neurol (Paris). 1980;136:303-309.
14. Scott TF, Bhagavatula K, Snyder PJ, et al. Transverse myelitis: comparison with spinal cord presentations of multiple sclerosis. Neurology. 1998;50:429-433.
15. Choi KH, Lee KS, Chung SO, et al. Idiopathic transverse myelitis: MR characteristics. Am J Neuroradiol. 1996;17:1151-1160.
16. Campi A, Filippi M, Comi G, et al. Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up. Am J Neuroradiol. 1995;16:115-123.
17. Murthy JMK, Reddy JJ, Meena AK, et al. Acute transverse myelitis: MR characteristics. Neurol India. 1999;4:290-293.
18. Misra UK, Kalita J, Kumar S. A clinical, MRI and neurophysiological study of acute transverse myelitis. J Neurol Sci. 1996;138:150-156.
19. Hoffman HL. Acute necrotic myelopathy. Brain. 1955;78:377-393.
20. Miller DH, McDonald WI, Blumhardt LD, et al. Magnetic resonance imaging in isolated noncompressive spinal cord syndromes. Ann Neurol. 1987;22:714-723.
21. Martinez HR. Tuberculosis del sistema nervioso central: conceptos actuales. Revista Mexicana Neurociencia. 2000;1:1.
22. Zuger A, Lowy FD. Tuberculosis of the brain, meninges, and spinal cord. In: Rom WN, Garay S, eds. Tuberculosis. Little Brown and Company; 1995:541-556.
23. Srivastava S, Sanghavi NG. Nontraumatic paraparesis: aetiological, clinical and radiological profile. J Assoc Physicians India. 2000;48:988-990.
24. Zenebe G, Oli K, Tekle-Haimanot R. Paraplegia at the Tikur Anbessa Teaching Hospital: a seven year retrospective study of 164 cases. Ethiop Med J. 1995;33:7-13.
25. Nyame PK. An aetiological survey of paraplegia in Accra. East Afr Med J. 1994;71:527-530.
26. Rhoton EL, Ballinger WE Jr, Quisling R, et al. Intramedullary spinal tuberculoma. Neurosurgery. 1988;22:733-736.
27. Choksey MS, Powell M, Gibb WR, et al. A conus tuberculoma mimicking an intramedullary tumour: a case report and review of the literature. Br J Neurosurg. 1989;3:117-121.
28. Ratliff JK, Connolly ES. Intramedullary tuberculoma of the spinal cord: case report and review of the literature. J Neurosurg. 1999;90:125-128.
29. Mac Donnell AH, Baird RW, Bronze MS. Intramedullary tuberculomas of the spinal cord: case report and review. Rev Infect Dis. 1990;12:432-439.
30. Kayaoglu CR, Tuzun Y, Boga Z, et al. Intramedullary spinal tuberculoma: a case report. Spine. 2000;25:2265-2268.
31. Banerjee AK, Chopra JS. Uncommon neurological presentations of tuberculoma. Clin Neurol Neurosurg. 1979;81:122-128.
32. Jacobs BC, Hazenberg MP, Van Doorn PA, et al. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome. J Infect Dis. 1997;175:729-733.
33. Goodyear CS, O'Hanlon GM, Plomp JJ, et al. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest. 1999;104:697-708.
34. Rees JH, Soudain SE, Gregson NA, et al. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med. 1995;333:1374-1379.
35. Mishu B, Ilyas AA, Koski C, et al. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med. 1993;118:947-953.
36. Blaser MJ, Olivares A, Taylor DN, et al. Campylobacter serology in patients with Chinese paralytic syndrome. Lancet. 1991;338:308.
37. Drulovic J, Dujmovic I, Stojsavlevic N, et al. Transverse myelopathy in the antiphospholipid antibody syndrome: pinworm infestation a trigger? J Neurol Neurosurg Psychiatry. 2000;68:249.
38. Jorens PG, VanderBorght A, Ceulemans B, et al. Encephalomyelitis- associated antimyelin autoreactivity induced by streptococcal exotoxins. Neurology. 2000;54:1433-1441.
39. Matsui M, Kakigi R, Watanabe S, et al. Recurrent demyelinating transverse myelitis in a high titer HBs-antigen carrier. J Neurol Sci. 1996;139:235-237.
40. White VLC, Al-Shahi R, Gamble E, et al. Transverse myelopathy and radiculomyelopathy associated with pulmonary atypical Mycobacterium infections. Thorax. 2001;56:158-160.
41. Case records of the Massachusetts General Hospital: case 33-2001. N Engl J Med. 2001;345:1263-1269.
42. Sebire G, Hollenberg H, Meyer L, et al. High dose methylprednisolone in severe acute transverse myelopathy. Arch Dis Child. 1997;76:167-168.
43. Lahat E, Pillar G, Ravid S, et al. Rapid recovery from transverse myelopathy in children treated with methylprednisolone. Pediatr Neurol. 1998;19:279-282.
44. Straub J, Chofflon M, Delavalle J. Early high-dose intravenous methylprednisolone in acute disseminated encephalomyelitis: a successful recovery. Neurology. 1997;49:1145-1147.
45. Schwarz S, Mohr A, Knauth M, et al. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology. 2001;56:1313-1318.
46. Dale RC, de Sousa C, Chong WK, et al. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain. 2000;123:2407-2422.
47. Pasternak JF, De Vivo DC, Prensky AL. Steroid responsive encephalomyelitis in childhood. Neurology. 1980;30:481-486.
48. Tippett DS, Fishman PS, Panitch HS. Relapsing transverse myelitis. Neurology. 1991;41:703-706.
49. Sahlas DJ, Miller SP, Guerin M, et al. Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology. 2000;54:1370-1372.
50. Nishikawa M, Ichiyama T, Hayashi T, et al. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. Pediatr Neurol. 1999;21:583-586.
51. Pradhan S, Gupta RP, Shashank S, et al. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. J Neurol Sci. 1999;165:56-61.
52. Weinsheker BG, O'Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999;46:878-886.
53. Rodriguez M, Karnes WE, Bartleson JD, et al. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology. 1993;43:1100-1104.
54. Kanter DS, Horensky D, Sperling RA, et al. Plasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology. 1995;45:824-827.
55. Kovascs B, Iaffererty TL, Brent LH, et al. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis. 2000;59:120-124.
56. Barile L, Lavalle C. Transverse myelitis in systemic lupus erythematosus: the effect of IV pulse methylprednisolone and cyclophosphamide. J Rheumatol. 1992;19:370-372.
57. Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology. 1998;51:1219-1220.